▶ 調査レポート

細胞治療技術のグローバル市場（2022年-2031年）：同種、自家
• 英文タイトル：Cell Therapy Technologies Market (Cell Type: Allogeneic and Autologous; Application: Cancer, Autoimmune Diseases, Cardiovascular Disorders, Orthopedic Disorder, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。細胞治療技術のグローバル市場（2022年-2031年）：同種、自家 / Cell Therapy Technologies Market (Cell Type: Allogeneic and Autologous; Application: Cancer, Autoimmune Diseases, Cardiovascular Disorders, Orthopedic Disorder, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2308A056資料のイメージです。• レポートコード：MRC2308A056
• 出版社/出版日：Transparency Market Research / 2023年6月15日
• レポート形態：英文、PDF、210ページ
• 納品方法：Eメール
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥869,250 (USD5,795)▷ お問い合わせ
  Multi User￥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License￥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
細胞治療技術市場 - レポートの範囲TMRの調査レポート「細胞治療技術の世界市場」は、2023年から2031年までの予測期間中に市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界の細胞治療技術市場の収益を提供します。また、2023年から2031年までの世界の細胞治療技術市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、細胞治療技術市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。

二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の細胞治療技術市場の様々な属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界の細胞治療技術市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場プレイヤーだけでなく、世界の細胞治療技術市場への参入に関心のある企業にとっても貴重なツールとなります。

当レポートでは、世界の細胞治療技術市場の競争環境について調査しています。世界の細胞治療技術市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介している世界の細胞治療技術市場のプレイヤーの項目です。

細胞治療技術の世界市場レポートが回答した主要な内容
- 予測期間中の全地域における細胞治療技術の売上高/収益
- 細胞治療技術の世界市場におけるビジネスチャンス
- 市場の主な促進要因、阻害要因、機会、脅威
- 予測期間中に最も速いCAGRで拡大する地域市場
- 2031年に世界で最も高い収益を上げると予測されるセグメント
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメント
- 世界市場で事業を展開する各企業の市場ポジション

細胞治療技術市場 - 調査目的と調査アプローチ
細胞治療技術の世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーや流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、過去と予測期間末の主要セグメントの市場シェアの比較も可能です。

当レポートでは、世界の細胞治療技術市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界の細胞治療技術への投資について、十分な情報に基づいたビジネス上の意思決定を行うことができます。

1. 序論
2. 仮定・調査手法
3. エグゼクティブサマリー
4. 市場概要
5. キーインサイト
6. 細胞治療技術の世界市場分析＆予測：細胞タイプ別
7. 細胞治療技術の世界市場分析＆予測：製品別
8. 細胞治療技術の世界市場分析＆予測：技術・手法別
9. 細胞治療技術の世界市場分析＆予測：用途別
10. 細胞治療技術の世界市場分析＆予測：地域別
11. 北米の細胞治療技術市場分析＆予測
12. ヨーロッパの細胞治療技術市場分析＆予測
13. アジア太平洋地域の細胞治療技術市場分析＆予測
14. 中南米の細胞治療技術市場分析＆予測
15. 中東・アフリカの細胞治療技術市場分析＆予測
16. 競争状況

レポート目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Therapy Technologies Market
4. Market Overview
    4.1. Introduction
        4.1.1. Market Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Cell Therapy Technologies Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Technological Advancements
    5.2. Overview of Cell Therapy Product Manufacturing Technologies
    5.3. List of Instruments and Consumables Used For Each of the Technologies
    5.4. Key Mergers & Acquisitions
    5.5. Top 3 Players Operating in the Market Space
6. Global Cell Therapy Technologies Market Analysis and Forecast, by Cell Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Cell Type, 2017-2031
        6.3.1. Allogeneic
            6.3.1.1. Blood Cells
            6.3.1.2. Others
        6.3.2. Autologous
            6.3.2.1. Human Embryonic Stem Cells
            6.3.2.2. Hematopoietic Stem Cells
            6.3.2.3. Mesenchymal Stem Cells
            6.3.2.4. Others
    6.4. Market Attractiveness Analysis, by Cell Type
7. Global Cell Therapy Technologies Market Analysis and Forecast, by Product
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Product, 2017-2031
        7.3.1. Tissue Digestion
            7.3.1.1. Instrumentation
            7.3.1.2. Consumables & Reagents
        7.3.2. Cell Selection/ Cell Isolation
            7.3.2.1. Instrumentation
            7.3.2.2. Consumables & Reagents
        7.3.3. Cell Viability Testing
            7.3.3.1. Instrumentation
            7.3.3.2. Consumables & Reagents
        7.3.4. Cell Transduction / Transfection
            7.3.4.1. Instrumentation
            7.3.4.2. Consumables & Reagents
        7.3.5. Cell Expansion
            7.3.5.1. Instrumentation
            7.3.5.2. Consumables & Reagents
        7.3.6. Quality Control Testing
            7.3.6.1. Instrumentation
            7.3.6.2. Consumables & Reagents
    7.4. Market Attractiveness Analysis, by Product
8. Global Cell Therapy Technologies Market Analysis and Forecast, by Technology/Method
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Technology/Method, 2017-2031
        8.3.1. Tissue Digestion
        8.3.2. Cell Selection/Cell Isolation
            8.3.2.1. Immunomagnetic Cell separation (IMS)
            8.3.2.2. Fluorescence-activated Cell Sorting(FACS)
            8.3.2.3. Density Gradient Centrifugation
            8.3.2.4. Microfluidic Cell Separation (MCS)
            8.3.2.5. Others
        8.3.3. Cell Viability Testing
            8.3.3.1. Tetrazolium Reduction Assay
            8.3.3.2. Protease Viability Marker Assay
            8.3.3.3. ATP Assay
            8.3.3.4. Real-Time Assay
            8.3.3.5. Others
        8.3.4. Cell Transduction/Transfection
            8.3.4.1. Cationic-lipid Mediated Transfection
            8.3.4.2. Calcium Phosphate Transfection
            8.3.4.3. Viral Transfection
            8.3.4.4. Electroporation
            8.3.4.5. Others
        8.3.5. Cell Expansion
            8.3.5.1. 3D Cell Culture
            8.3.5.2. Roller Bottle Culture
            8.3.5.3. Cell Culture Scale-up Systems
            8.3.5.4. Spinner Flask Culture
            8.3.5.5. Others
        8.3.6. Quality Control Testing
            8.3.6.1. Endotoxin
            8.3.6.2. Mycoplasma
            8.3.6.3. Others
    8.4. Market Attractiveness Analysis, by Technology/Method
9. Global Cell Therapy Technologies Market Analysis and Forecast, by Application
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by Application, 2017-2031
        9.3.1. Cancer
        9.3.2. Autoimmune Diseases
        9.3.3. Cardiovascular Disorders
        9.3.4. Orthopedic Disorders
        9.3.5. Others
    9.4. Market Attractiveness Analysis, by Application
10. Global Cell Therapy Technologies Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, by Region
11. North America Cell Therapy Technologies Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Cell Type, 2017-2031
        11.2.1. Allogeneic
            11.2.1.1. Blood Cells
            11.2.1.2. Others
        11.2.2. Autologous
            11.2.2.1. Human Embryonic Stem Cells
            11.2.2.2. Hematopoietic Stem Cells
            11.2.2.3. Mesenchymal Stem Cells
            11.2.2.4. Others
    11.3. Market Value Forecast, by Product, 2017-2031
        11.3.1. Tissue Digestion
            11.3.1.1. Instrumentation
            11.3.1.2. Consumables & Reagents
        11.3.2. Cell Selection/ Cell Isolation
            11.3.2.1. Instrumentation
            11.3.2.2. Consumables & Reagents
        11.3.3. Cell Viability Testing
            11.3.3.1. Instrumentation
            11.3.3.2. Consumables & Reagents
        11.3.4. Cell Transduction / Transfection
            11.3.4.1. Instrumentation
            11.3.4.2. Consumables & Reagents
        11.3.5. Cell Expansion
            11.3.5.1. Instrumentation
            11.3.5.2. Consumables & Reagents
        11.3.6. Quality Control Testing
            11.3.6.1. Instrumentation
            11.3.6.2. Consumables & Reagents
    11.4. Market Value Forecast, by Technology/Method, 2017-2031
        11.4.1. Tissue Digestion
        11.4.2. Cell Selection/Cell Isolation
            11.4.2.1. Immunomagnetic Cell separation (IMS)
            11.4.2.2. Fluorescence-activated Cell Sorting(FACS)
            11.4.2.3. Density Gradient Centrifugation
            11.4.2.4. Microfluidic Cell Separation (MCS)
            11.4.2.5. Others
        11.4.3. Cell Viability Testing
            11.4.3.1. Tetrazolium Reduction Assay
            11.4.3.2. Protease Viability Marker Assay
            11.4.3.3. ATP Assay
            11.4.3.4. Real-Time Assay
            11.4.3.5. Others
        11.4.4. Cell Transduction/Transfection
            11.4.4.1. Cationic-lipid Mediated Transfection
            11.4.4.2. Calcium Phosphate Transfection
            11.4.4.3. Viral Transfection
            11.4.4.4. Electroporation
            11.4.4.5. Others
        11.4.5. Cell Expansion
            11.4.5.1. 3D Cell Culture
            11.4.5.2. Roller Bottle Culture
            11.4.5.3. Cell Culture Scale-up Systems
            11.4.5.4. Spinner Flask Culture
            11.4.5.5. Others
        11.4.6. Quality Control Testing
            11.4.6.1. Endotoxin
            11.4.6.2. Mycoplasma
            11.4.6.3. Others
    11.5. Market Value Forecast, by Application, 2017-2031
        11.5.1. Cancer
        11.5.2. Autoimmune Diseases
        11.5.3. Cardiovascular Disorders
        11.5.4. Orthopedic Disorders
        11.5.5. Others
    11.6. Market Value Forecast, by Country, 2017-2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Cell Type
        11.7.2. By Product
        11.7.3. By Technology/Method
        11.7.4. By Application
        11.7.5. By Country
12. Europe Cell Therapy Technologies Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Cell Type, 2017-2031
        12.2.1. Allogeneic
            12.2.1.1. Blood Cells
            12.2.1.2. Others
        12.2.2. Autologous
            12.2.2.1. Human Embryonic Stem Cells
            12.2.2.2. Hematopoietic Stem Cells
            12.2.2.3. Mesenchymal Stem Cells
            12.2.2.4. Others
    12.3. Market Value Forecast, by Product, 2017-2031
        12.3.1. Tissue Digestion
            12.3.1.1. Instrumentation
            12.3.1.2. Consumables & Reagents
        12.3.2. Cell Selection/ Cell Isolation
            12.3.2.1. Instrumentation
            12.3.2.2. Consumables & Reagents
        12.3.3. Cell Viability Testing
            12.3.3.1. Instrumentation
            12.3.3.2. Consumables & Reagents
        12.3.4. Cell Transduction / Transfection
            12.3.4.1. Instrumentation
            12.3.4.2. Consumables & Reagents
        12.3.5. Cell Expansion
            12.3.5.1. Instrumentation
            12.3.5.2. Consumables & Reagents
        12.3.6. Quality Control Testing
            12.3.6.1. Instrumentation
            12.3.6.2. Consumables & Reagents
    12.4. Market Value Forecast, by Technology/Method, 2017-2031
        12.4.1. Cell Selection/Cell Isolation
            12.4.1.1. Immunomagnetic Cell separation (IMS)
            12.4.1.2. Fluorescence-activated Cell Sorting(FACS)
            12.4.1.3. Density Gradient Centrifugation
            12.4.1.4. Microfluidic Cell Separation (MCS)
            12.4.1.5. Others
        12.4.2. Cell Viability Testing
            12.4.2.1. Tetrazolium Reduction Assay
            12.4.2.2. Protease Viability Marker Assay
            12.4.2.3. ATP Assay
            12.4.2.4. Real-Time Assay
            12.4.2.5. Others
        12.4.3. Cell Transduction/Transfection
            12.4.3.1. Cationic-lipid Mediated Transfection
            12.4.3.2. Calcium Phosphate Transfection
            12.4.3.3. Viral Transfection
            12.4.3.4. Electroporation
            12.4.3.5. Others
        12.4.4. Cell Expansion
            12.4.4.1. 3D Cell Culture
            12.4.4.2. Roller Bottle Culture
            12.4.4.3. Cell Culture Scale-up Systems
            12.4.4.4. Spinner Flask Culture
            12.4.4.5. Others
        12.4.5. Quality Control Testing
            12.4.5.1. Endotoxin
            12.4.5.2. Mycoplasma
            12.4.5.3. Others
    12.5. Market Value Forecast, by Application, 2017-2031
        12.5.1. Cancer
        12.5.2. Autoimmune Diseases
        12.5.3. Cardiovascular Disorders
        12.5.4. Orthopedic Disorders
        12.5.5. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Cell Type
        12.7.2. By Product
        12.7.3. By Technology/Method
        12.7.4. By Application
        12.7.5. By Country/Sub-region
13. Asia Pacific Cell Therapy Technologies Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Cell Type, 2017-2031
        13.2.1. Allogeneic
            13.2.1.1. Blood Cells
            13.2.1.2. Others
        13.2.2. Autologous
            13.2.2.1. Human Embryonic Stem Cells
            13.2.2.2. Hematopoietic Stem Cells
            13.2.2.3. Mesenchymal Stem Cells
            13.2.2.4. Others
    13.3. Market Value Forecast, by Product, 2017-2031
        13.3.1. Tissue Digestion
            13.3.1.1. Instrumentation
            13.3.1.2. Consumables & Reagents
        13.3.2. Cell Selection/ Cell Isolation
            13.3.2.1. Instrumentation
            13.3.2.2. Consumables & Reagents
        13.3.3. Cell Viability Testing
            13.3.3.1. Instrumentation
            13.3.3.2. Consumables & Reagents
        13.3.4. Cell Transduction / Transfection
            13.3.4.1. Instrumentation
            13.3.4.2. Consumables & Reagents
        13.3.5. Cell Expansion
            13.3.5.1. Instrumentation
            13.3.5.2. Consumables & Reagents
        13.3.6. Quality Control Testing
            13.3.6.1. Instrumentation
            13.3.6.2. Consumables & Reagents
    13.4. Market Value Forecast, by Technology/Method, 2017-2031
        13.4.1. Tissue Digestion
        13.4.2. Cell Selection/Cell Isolation
            13.4.2.1. Immunomagnetic Cell separation (IMS)
            13.4.2.2. Fluorescence-activated Cell Sorting(FACS)
            13.4.2.3. Density Gradient Centrifugation
            13.4.2.4. Microfluidic Cell Separation (MCS)
            13.4.2.5. Others
        13.4.3. Cell Viability Testing
            13.4.3.1. Tetrazolium Reduction Assay
            13.4.3.2. Protease Viability Marker Assay
            13.4.3.3. ATP Assay
            13.4.3.4. Real-Time Assay
            13.4.3.5. Others
        13.4.4. Cell Transduction/Transfection
            13.4.4.1. Cationic-lipid Mediated Transfection
            13.4.4.2. Calcium Phosphate Transfection
            13.4.4.3. Viral Transfection
            13.4.4.4. Electroporation
            13.4.4.5. Others
        13.4.5. Cell Expansion
            13.4.5.1. 3D Cell Culture
            13.4.5.2. Roller Bottle Culture
            13.4.5.3. Cell Culture Scale-up Systems
            13.4.5.4. Spinner Flask Culture
            13.4.5.5. Others
        13.4.6. Quality Control Testing
            13.4.6.1. Endotoxin
            13.4.6.2. Mycoplasma
            13.4.6.3. Others
    13.5. Market Value Forecast, by Application, 2017-2031
        13.5.1. Cancer
        13.5.2. Autoimmune Diseases
        13.5.3. Cardiovascular Disorders
        13.5.4. Orthopedic Disorders
        13.5.5. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Cell Type
        13.7.2. By Product
        13.7.3. By Technology/Method
        13.7.4. By Application
        13.7.5. By Country/Sub-region
14. Latin America Cell Therapy Technologies Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Cell Type, 2017-2031
        14.2.1. Allogeneic
            14.2.1.1. Blood Cells
            14.2.1.2. Others
        14.2.2. Autologous
            14.2.2.1. Human Embryonic Stem Cells
            14.2.2.2. Hematopoietic Stem Cells
            14.2.2.3. Mesenchymal Stem Cells
            14.2.2.4. Others
    14.3. Market Value Forecast, by Product, 2017-2031
        14.3.1. Tissue Digestion
            14.3.1.1. Instrumentation
            14.3.1.2. Consumables & Reagents
        14.3.2. Cell Selection/ Cell Isolation
            14.3.2.1. Instrumentation
            14.3.2.2. Consumables & Reagents
        14.3.3. Cell Viability Testing
            14.3.3.1. Instrumentation
            14.3.3.2. Consumables & Reagents
        14.3.4. Cell Transduction / Transfection
            14.3.4.1. Instrumentation
            14.3.4.2. Consumables & Reagents
        14.3.5. Cell Expansion
            14.3.5.1. Instrumentation
            14.3.5.2. Consumables & Reagents
        14.3.6. Quality Control Testing
            14.3.6.1. Instrumentation
            14.3.6.2. Consumables & Reagents
    14.4. Market Value Forecast, by Technology/Method, 2017-2031
        14.4.1. Tissue Digestion
        14.4.2. Cell Selection/Cell Isolation
            14.4.2.1. Immunomagnetic Cell separation (IMS)
            14.4.2.2. Fluorescence-activated Cell Sorting(FACS)
            14.4.2.3. Density Gradient Centrifugation
            14.4.2.4. Microfluidic Cell Separation (MCS)
            14.4.2.5. Others
        14.4.3. Cell Viability Testing
            14.4.3.1. Tetrazolium Reduction Assay
            14.4.3.2. Protease Viability Marker Assay
            14.4.3.3. ATP Assay
            14.4.3.4. Real-Time Assay
            14.4.3.5. Others
        14.4.4. Cell Transduction/Transfection
            14.4.4.1. Cationic-lipid Mediated Transfection
            14.4.4.2. Calcium Phosphate Transfection
            14.4.4.3. Viral Transfection
            14.4.4.4. Electroporation
            14.4.4.5. Others
        14.4.5. Cell Expansion
            14.4.5.1. 3D Cell Culture
            14.4.5.2. Roller Bottle Culture
            14.4.5.3. Cell Culture Scale-up Systems
            14.4.5.4. Spinner Flask Culture
            14.4.5.5. Others
        14.4.6. Quality Control Testing
            14.4.6.1. Endotoxin
            14.4.6.2. Mycoplasma
            14.4.6.3. Others
    14.5. Market Value Forecast, by Application, 2017-2031
        14.5.1. Cancer
        14.5.2. Autoimmune Diseases
        14.5.3. Cardiovascular Disorders
        14.5.4. Orthopedic Disorders
        14.5.5. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Cell Type
        14.7.2. By Product
        14.7.3. By Technology/Method
        14.7.4. By Application
        14.7.5. By Country/Sub-region
15. Middle East & Africa Cell Therapy Technologies Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Cell Type, 2017-2031
        15.2.1. Allogeneic
            15.2.1.1. Blood Cells
            15.2.1.2. Others
        15.2.2. Autologous
            15.2.2.1. Human Embryonic Stem Cells
            15.2.2.2. Hematopoietic Stem Cells
            15.2.2.3. Mesenchymal Stem Cells
            15.2.2.4. Others
    15.3. Market Value Forecast, by Product, 2017-2031
        15.3.1. Tissue Digestion
            15.3.1.1. Instrumentation
            15.3.1.2. Consumables & Reagents
        15.3.2. Cell Selection/ Cell Isolation
            15.3.2.1. Instrumentation
            15.3.2.2. Consumables & Reagents
        15.3.3. Cell Viability Testing
            15.3.3.1. Instrumentation
            15.3.3.2. Consumables & Reagents
        15.3.4. Cell Transduction / Transfection
            15.3.4.1. Instrumentation
            15.3.4.2. Consumables & Reagents
        15.3.5. Cell Expansion
            15.3.5.1. Instrumentation
            15.3.5.2. Consumables & Reagents
        15.3.6. Quality Control Testing
            15.3.6.1. Instrumentation
            15.3.6.2. Consumables & Reagents
    15.4. Market Value Forecast, by Technology/Method, 2017-2031
        15.4.1. Tissue Digestion
        15.4.2. Cell Selection/Cell Isolation
            15.4.2.1. Immunomagnetic Cell separation (IMS)
            15.4.2.2. Fluorescence-activated Cell Sorting(FACS)
            15.4.2.3. Density Gradient Centrifugation
            15.4.2.4. Microfluidic Cell Separation (MCS)
            15.4.2.5. Others
        15.4.3. Cell Viability Testing
            15.4.3.1. Tetrazolium Reduction Assay
            15.4.3.2. Protease Viability Marker Assay
            15.4.3.3. ATP Assay
            15.4.3.4. Real-Time Assay
            15.4.3.5. Others
        15.4.4. Cell Transduction/Transfection
            15.4.4.1. Cationic-lipid Mediated Transfection
            15.4.4.2. Calcium Phosphate Transfection
            15.4.4.3. Viral Transfection
            15.4.4.4. Electroporation
            15.4.4.5. Others
        15.4.5. Cell Expansion
            15.4.5.1. 3D Cell Culture
            15.4.5.2. Roller Bottle Culture
            15.4.5.3. Cell Culture Scale-up Systems
            15.4.5.4. Spinner Flask Culture
            15.4.5.5. Others
        15.4.6. Quality Control Testing
            15.4.6.1. Endotoxin
            15.4.6.2. Mycoplasma
            15.4.6.3. Others
    15.5. Market Value Forecast, by Application, 2017-2031
        15.5.1. Cancer
        15.5.2. Autoimmune Diseases
        15.5.3. Cardiovascular Disorders
        15.5.4. Orthopedic Disorders
        15.5.5. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Cell Type
        15.7.2. By Product
        15.7.3. By Technology/Method
        15.7.4. By Application
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Share Analysis, by Company, 2022
    16.2. Company Profiles
        16.2.1. Agilent Technologies
            16.2.1.1. Company Overview
            16.2.1.2. Financial Overview
            16.2.1.3. Product Portfolio
            16.2.1.4. Business Strategies
            16.2.1.5. Recent Developments
        16.2.2. Merck KGaA
            16.2.2.1. Company Overview
            16.2.2.2. Financial Overview
            16.2.2.3. Product Portfolio
            16.2.2.4. Business Strategies
            16.2.2.5. Recent Developments
        16.2.3. Thermo Fisher Scientific, Inc.
            16.2.3.1. Company Overview
            16.2.3.2. Financial Overview
            16.2.3.3. Product Portfolio
            16.2.3.4. Business Strategies
            16.2.3.5. Recent Developments
        16.2.4. Miltenyi Biotech
            16.2.4.1. Company Overview
            16.2.4.2. Financial Overview
            16.2.4.3. Product Portfolio
            16.2.4.4. Business Strategies
            16.2.4.5. Recent Developments
        16.2.5. GE Healthcare (General Electric Company)
            16.2.5.1. Company Overview
            16.2.5.2. Financial Overview
            16.2.5.3. Product Portfolio
            16.2.5.4. Business Strategies
            16.2.5.5. Recent Developments
        16.2.6. Beckman Coulter, Inc. (Danaher)
            16.2.6.1. Company Overview
            16.2.6.2. Financial Overview
            16.2.6.3. Product Portfolio
            16.2.6.4. Business Strategies
            16.2.6.5. Recent Developments
        16.2.7. Sartorius AG
            16.2.7.1. Company Overview
            16.2.7.2. Financial Overview
            16.2.7.3. Product Portfolio
            16.2.7.4. Business Strategies
            16.2.7.5. Recent Developments
        16.2.8. Lonza Group
            16.2.8.1. Company Overview
            16.2.8.2. Financial Overview
            16.2.8.3. Product Portfolio
            16.2.8.4. Business Strategies
            16.2.8.5. Recent Developments
        16.2.9. Terumo Corporation
            16.2.9.1. Company Overview
            16.2.9.2. Financial Overview
            16.2.9.3. Product Portfolio
            16.2.9.4. Business Strategies
            16.2.9.5. Recent Developments
        16.2.10. Curate Biosciences
            16.2.10.1. Company Overview
            16.2.10.2. Financial Overview
            16.2.10.3. Product Portfolio
            16.2.10.4. Business Strategies
            16.2.10.5. Recent Developments

List of Tables

Table 01: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

Table 02: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

Table 03: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

Table 04: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 05: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 06: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 07: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 08: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 09: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 10: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 04: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

Table 11: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 12: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 13: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 14: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 15: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 16: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 17: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 18: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 19: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 20: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

Table 21: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

Table 22: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

Table 23: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 24: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 25: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 26: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 27: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 28: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 29: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 23: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method 2017-2031

Table 30: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 31: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 32: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 33: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 34: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 35: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 36: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 37: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 38: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

Table 39: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

Table 40: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

Table 41: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 42: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 43: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation by Product, 2017-2031

Table 44: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 45: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection by Product, 2017-2031

Table 46: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 47: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 48: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

Table 49: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 50: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 51: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 52: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 53: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 54: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 55: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 56: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 57: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

Table 58: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

Table 59: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

Table 60: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 61: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 62: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031

Table 63: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 64: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection by Product, 2017-2031

Table 65: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 66: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 67: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

Table 68: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 69: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 70: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 71: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 72: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 73: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 74: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 75: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 76: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

Table 77: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

Table 78: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

Table 79: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 80: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 81: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031

Table 82: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 83: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction /Transfection, 2017-2031

Table 84: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 85: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 86: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031

Table 87: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 88: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 89: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 90: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 91: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 92: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 93: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 94: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 95: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031

Table 96: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031

Table 97: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031

Table 98: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 99: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 100: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031

Table 101: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 102: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction /Transfection, 2017-2031

Table 103: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 104: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 105: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method 2017-2031

Table 106: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031

Table 107: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031

Table 108: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031

Table 109: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031

Table 110: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031

Table 111: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031

Table 112: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
以下、関連資料のご紹介
  • 移植診断のグローバル市場（2023年-2031年）：移植前診断、移植後診断
    Transplant Diagnostics Market (Screening: Pre-transplant Diagnostics and Post-transplant Diagnostics; and Technique: Molecular Assay and Non-molecular Assay) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
    MRC2403B364 2023年12月 295Pages
    移植診断市場 - レポートの範囲TMRの調査レポート「世界の移植診断市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から203...
  • 細胞・遺伝子療法製造のグローバル市場（2023年-2031年）：細胞療法、遺伝子療法
    Cell and Gene Therapy Manufacturing Market (Therapy Type: Cell Therapy and Gene Therapy; Product Type: Consumables, Equipment, and Software) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
    MRC2312A088 2023年8月24日 284Pages
    細胞・遺伝子療法製造市場 - レポートの範囲TMRの調査レポート「世界の細胞・遺伝子療法製造市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年か...
  • マルチパラメーターin vitro心毒性検査のグローバル市場（2022年-2031年）：カルシウムトランジェントアッセイ、心臓マーカー検出、hERGアッセイ、マルチイオンチャネルアッセイ、その他
    Multiparametric In-vitro Cardiotoxicity Testing Market (Type of Assay: Calcium Transient Assay, Cardiac Marker Detection, hERG Assay, Multi-ion Channel Assay, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
    MRC2304D144 2023年1月6日 167Pages
    Transparency Market Research社の当調査レポートでは、マルチパラメーターin vitro心毒性検査の世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、アッセイ種類別（カルシウムトランジェントアッセ...
  • 新型コロナウイルス感染症用診断のグローバル市場（2022年-2031年）：機器、試薬＆キット
    COVID-19 Diagnostics Market (Product: Instruments and Reagents & Kits; Test Type: Molecular Tests, Antigen Tests, and Antibody Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
    MRC2304D084 2023年1月24日 226Pages
    Transparency Market Research社の当調査レポートでは、新型コロナウイルス感染症用診断の世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、市場分析＆予測、製品別（機器、試薬＆キット）分析、検査種類別...
  • HIV/AIDS診断のグローバル市場（2022年-2031年）：キット＆試薬、機器
    HIV/AIDS Diagnostics Market (Product: Kits and Reagents and Instruments; and Test Type: Nucleic Acid Tests, Rapid Tests, ELISA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
    MRC2304D096 2023年1月10日 180Pages
    Transparency Market Research社の当調査レポートでは、HIV/AIDS診断の世界市場を分析し、市場実態を明らかにしています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（キット＆試薬、機器）分析、検査種類別（核酸検査、迅速検査、EL...